ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 911

Race- and Sex-Specific Estimates of 10-, 20-, 30-Year, and Lifetime Risk of Diagnosed Symptomatic Knee Osteoarthritis and the Need for TKR in the US

Elena Losina1, Meghan E. Daigle1, Sara A. Burbine1 and Jeffrey N. Katz2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, osteoarthritis and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: A growing body of evidence suggests that females are more likely to be diagnosed with knee osteoarthritis (OA) and that obesity increases the risk of knee OA. Population-based studies suggest that Black and Hispanic females have a greater likelihood of being obese than White females. Sex- and race/ethnicity-specific risks of diagnosed symptomatic knee OA and the need for TKR have not been estimated.

Methods: We combined the OAPol Model – a validated state-transition, computer simulation model – with published data on the incidence of OA, stratified by sex and obesity. Obesity prevalence, stratified by sex and race/ethnicity, was derived from published literature and ranged from 19% for White males to 34% for Black females. The increased risk of symptomatic knee OA conferred by obesity was derived from published studies (RR = 1.7). Rates of progression of knee OA were derived from the Johnston County Osteoarthritis Project and calibrated to published data. The annual incidence of TKR among persons with advanced knee OA (Kellgren-Lawrence grade 3 or 4) was derived using data from two national longitudinal studies of persons with knee OA (Multicenter Osteoarthritis Study and Osteoarthritis Initiative). Input parameters related to mortality, obesity, comorbidities, non-surgical OA treatments, and implant failure were obtained from national survey data and published literature. Using the OAPol Model we estimated the 10-year, 20-year, 30-year and lifetime risks of diagnosed symptomatic knee OA and TKR from age 40, stratified by race and sex.

Results: In persons free of knee OA at age 40, the lifetime risk of diagnosed symptomatic knee OA ranged from 10% among White males to 17% among Black females (Figure). The 20-year risk of diagnosed symptomatic knee OA ranged from about 6% in males (race/ethnicity did not affect the rate meaningfully) to 8% in Black females. By age 65, 11.3%, 10.5%, and 10% of Black, Hispanic, and White females, free of knee OA at age 40, will be diagnosed with symptomatic knee OA (Figure). Lifetime need for TKR ranged from 3.8% for Hispanic males to 6.8% for Black females. 

Conclusion: Lifetime risk of diagnosed symptomatic knee OA varies by age and race/ethnicity. Black females are more likely to be obese, which corresponds with their having the greatest lifetime risk of being diagnosed with knee OA and needing TKR. Race- and sex-tailored weight management programs may reduce the lifetime risk of knee OA.  

 


Disclosure:

E. Losina,
None;

M. E. Daigle,
None;

S. A. Burbine,
None;

J. N. Katz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/race-and-sex-specific-estimates-of-10-20-30-year-and-lifetime-risk-of-diagnosed-symptomatic-knee-osteoarthritis-and-the-need-for-tkr-in-the-us/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology